FDA Approval Status: The Unapproved Drug Classification Is BPC-157 FDA-approved for human use
Preclinical Evidence Across Tissue Types Soft Tissue (Muscle, Tendon, and Ligament) Models: Many rodent studies have examined BPC-157 in models of musculoskeletal injury: In rat tendon and ligament injury experiments, administration of BPC-157 accelerated collagen organization and improved measures of biomechanical integrity relative to untreated controls (4)
Its not a hormone or a painkiller
Within the GI system, BPC-157 has been characterised across stomach, duodenum, small intestine, colon, and oesophagus in models of ulceration, NSAID toxicity, ethanol damage, inflammatory bowel disease, and anastomotic healing, Tendon and ligament research represents the second most extensively documented tissue application